Springer Nature has put together an open-access virtual issue around the current Zika virus crisis. The goal of making this content available is for Springer Nature to help students, researchers, health care professionals, and other scientifically minded individuals to better understand the multidisciplinary approach to containing the virus and caring for patients.
The research has been organized into various disciplines and made freely available – this includes articles, commentaries, blog posts and news items. View all of the available content.
Particularly of interest to members of MassBio is the discipline on Pharmacology. Open-access links to 24 drug profiles and 3 clinical trial profiles from Adis Insight relevant to the Zika virus are included. Click here to view the full profiles. Interested in learning more or setting up a trial of Adis Insight? Please contact Caitlin.Cricco@springernature.com.
Springer Nature is a Purchasing Consortium Member – members of MassBio with under 99 R&D staff members receive exclusive discounts, click here to learn more.